Empowered Funds’s Perspective Therapeutics CATX Stock Holding History

Empowered Funds’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$338K	Buy	+122,894	New	+$373K	﹤0.01%	1986

Other funds holding CATX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

Spruce Street Capital New York $629M AUM 210.46% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Nicholson Wealth Management Group Charlestown, South Carolina $168M AUM 6.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Empowered Funds's CATX Position: Q3 2026 in Review

Empowered Funds opened a new position in Perspective Therapeutics (CATX) in Q3 2026: 122,894 shares worth $338K. The stake represents ﹤0.01% of the portfolio and ranks #1986 among its holdings.

77 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

Empowered Funds held 122,894 shares of Perspective Therapeutics worth $338K as of Q3 2026.
Perspective Therapeutics was a new Empowered Funds position in Q3 2026.
Perspective Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #1986 holding.
77 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.